Abstract
Given the increasing incidence of thyroid cancer cases affecting the pediatric population in Europe, an epidemiological analysis of the available data is essential in order to update standards of care and recommend diagnostic and therapeutic strategies coherent to the new epidemiological trend. An observational study was conducted, considering the time interval 1991–2012, acquiring data collected by the International Agency for Research on Cancer (IARC) through the “Cancer Incidence in 5 continents plus” (CI5 plus) project and dividing patients into four groups of age (0–4, 5–9, 10–14, 15–19 years old). Data retrieved were compared to the latest report from Global Cancer Observatory, collected through the GLOBOCAN 2020 project, dividing patients in two groups: age 10–14, 15–19. Our findings highlighted an increasing prevalence of thyroid cancer rates in patients aged from 10 to 15 years old and from 15 to 19 years old, mainly in the female population, in Belarus (from 1991 to 2007), Cyprus, and Italy (from 2008 to 2012). Moreover, a further increase in incidence was highlighted in Italy according to data from GLOBOCAN 2020, with respect to other European countries.
Conclusion: An increasing prevalence of thyroid cancer is seen in age groups 10–19. Further research is required to understand the underlying cause and concomitantly identify the most proper screening and diagnostic techniques of thyroid nodules. Indeed, this is crucial to reach optimal surgical standards and better prognosis, possibly with more conservative approaches and maybe less postoperative complications.
What is Known: • Thyroid cancer is the 4th most common malignancy in children. | |
What is New: • In the last decades, an increasing pattern has been recorded. • In the US, it has outlined breast cancers as the most common cancer in females. |
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Thyroid carcinoma (TC) is the fourth most common tumor in the pediatric population and the most frequent endocrine malignancy, especially in females [1, 2]. During the last decades, an increasing pattern in terms of incidence has been observed worldwide [3]. The exact underlying causes are far to be known, but possible explanations may reside in the increased presence of known risk factors, such as obesity and exposure to ionizing radiations. The former has been proven to be correlated to as TC development due to adiponectin secretion and leptin inhibition [4]. Moreover, in recent years, numerous reports have focused on environmental factors such as pollution, diet, and lifestyle, reporting that exposure to endocrine disruptors such as polybromurates (PDBEs) and heavy metals alter thyroid function and are associated with an increased risk of thyroid cancer [5]. It must also be underlined that the frequency of autoimmune thyroiditis, which is the most common cause of primary hypothyroidism, has increased in recent times: the underlying autoimmune process and subsequent secretion of proinflammatory cytokines promote the development of an inflammatory environment which may play a role in increasing the risk of malignancy [6]. On the other hand, an increasingly enhanced use of imaging techniques such as ultrasound as a standard diagnostic tool promoted surveillance of neck nodules and may have led to overdiagnosis of thyroid nodules in the pediatric population [7, 8].
This increasing pattern in TC has also been recorded in the USA, where in terms of proportions TC has outlined breast cancer as the most common cancer in females [1]. Increasing incidence in Europe has been observed thanks to the data collected through projects such as the Cancer Incidence 5 Plus project and the Global Cancer Observatory and International Agency for Research on Cancer, both coordinated by the World Health Organization. These projects traced the number of cases of TC worldwide and collected them on an online platform, making them accessible to everyone. In the light of the new TC trend, an epidemiological analysis of the available data regarding European countries is essential. Indeed, by analyzing the new incidence and prevalence patterns of the disease, improvements in both screening and diagnostic processes can be achieved. The latter will consequently lead to earlier diagnosis and more prompt treatment, possibly with more conservative approaches and better therapeutical strategies.
We compared data collected from 1991 to 2012 with the latest reports of the GLOBOCAN 2020 project, to evaluate the latest epidemiological trend to suggest proper screening and diagnostic strategies, eventually intended to propose better therapeutic approaches accordingly.
Materials and methods
The incidence of TC in the following countries was considered, referring through the CI5plus database [9]: Belarus, Austria, Bulgaria, Croatia, Cyprus, Czech Republic, France (9 registers), Germany (2 registers), Italy (8 registers), Spain (9 registers). Other European countries were not taken into consideration given the absence of specific epidemiological relevance. Incidence was calculated and expressed per 100,000 inhabitants.
Data retrieved during the time frame from 1991 to 2012 divided the pediatric population into 4 groups: 0–4 years old, 5–9 years old, 10–14 years old, 15–19 years old. Data from 1991 to 1998 were available only for Belarus. With respect to Austria, Bulgaria, France, Germany, Italy, and Cyprus, no data were available for the year 1997. Italy and France are lacking data of years 2011 and 2012. Regarding TC incidence in 2020 of all the aforementioned countries instead, data were collected through the GLOBOCAN 2020 database. Patients were grouped according to age into 2 groups: 10–14 years old, 15–19 years old.
Data from males and females were analyzed separately in all cases. The data were analyzed by drawing polynomial trend lines of various degrees (from 2nd to 6th), with an R-squared (correlation index) > 0.5 reinforcing the correlation (not available graphics).
Results
Age group
Belarus
From 1991 to 1995, all age groups were consistently affected by TC, with female patients aged 5–9 years old presenting a peak of 8.0 cases/100,000 inhabitants in 1993. Subsequently, a rising trend was observed, involving almost exclusively the 10–14-year-old group and the 15–19-year-old group. The former reached its incidence peak in 1996 (F: 13.4 cases/100,000 inhabitants; M: 8.2 cases/100,000 inhabitants). The 15–19-year-old group instead peaked in 2001–2002, followed by a decrease until 2006 and 2007. From 2007, a steep rise until 2012 occurred.
Other countries
During the time from 1998 to 2012, the incidence of TC was almost stable in all the European countries analyzed. Data from the GLOBOCAN 2020 project highlight a substantial increase in the incidence of TC and confirm late adolescents (15–19 years old) to be the most affected population. Differences among the two age groups were subtle, with a slight increase of cases in adolescents aged 15–19 years old. In 2020, major differences were found with respect to the age group considered: female late adolescents indeed presented a much higher incidence with respect to girls aged 10–14 years old. Regarding the latter group, Croatia and Czech Republic recorded 0 new cases in 2020 (Figs. 1 and 2).
Gender differences
Belarus
From 1991 to 2012, the incidence of TC in Belarus presented a similar trend in both the female and male populations. The pattern of distribution was almost superimposable for both genders in all age groups. In the age group 10–14 years old, the incidence in both genders decreased from 1996 to 2001. Then, a steady increase began and continued until 2012.
Instead, the population aged 15–19 years old presented a marked difference between the two genders: in 2001–2002, the incidence in male was 6.2 cases/100,000 inhabitants), while females almost doubled it with 14.8 cases/100,000 inhabitants (Supplementary Fig. 1).
Other countries
From 1998 to 2012, a slightly increasing trend was observed in Croatia, Czech Republic, Italy, and Germany with respect to the female population, while the incidence decreased in France and Bulgaria. Regarding the male population instead, Czech Republic and Bulgaria recorded an increased number of cases, while Spain, Italy, and France registered a decreasing pattern (Figs. 3 and 4). Regarding the male population, an incidence peak occurred in Cyprus (5.2 cases/100,000 inhabitants), while the other countries presented a comparable incidence.
In 2020, in the female population, the highest incidence was recorded in Italy (17.3 cases/100,000 inhabitants), followed by Cyprus (14.1 cases/100,000 inhabitants) and Croatia (8.4 cases/100,000 inhabitants). Findings regarding this group were consistent also regarding other countries, with Belarus presenting > 7.4 cases/100,000 inhabitants and France having 7.5 cases/100,000 inhabitants.
The global incidence of thyroid cancer in European countries in 2020 presents some interesting data, such as an increase of almost tenfold in the female population in Italy (10.1 cases/100,000 inhabitants), in Croatia (6.1 cases/100,000 inhabitants), and in France (4.1 cases/100,000 inhabitants). Regarding males instead, Cyprus reached 2.6 cases/100,000 inhabitants and Czech Republic estimated almost 1 case/100,000 (Supplementary Figs. 2 and 3).
Discussion
The incidence of thyroid cancer has progressively increased worldwide [10]. This analysis presents Belarus, Cyprus, and Italy as the countries mostly affected by thyroid cancer in the pediatric population. In addition, it must be emphasized that Italy presents a greater number of cases when compared to other countries, with the exception of Cyprus. Conversely, Belarus shows a stable high incidence during all time periods evaluated in the present study. The causes behind this increasing pattern are still a matter of debate in the scientific community and they are most likely multifactorial. The exposure to ionizing radiation is a well-established and documented risk factor for thyroid cancer development, as demonstrated by the surge of thyroid cancer following the Chernobyl accident in 1986 [11, 12]. Iodine deficiency causes thyroid stimulation upon TSH secretion which ultimately promotes follicular cell growth [13]. Our study supports this theory from an epidemiological point of view. Belarus data showing an increase of thyroid cancer cases in all age groups, even patients aged 0–4 years old who are hardly ever involved in the other countries, was observed, likely due to the increased population’s exposure to ionizing radiations [12, 14]. The correlation is striking when looking at the pattern of distribution of thyroid cancer, given the high number of cases recorded in the years following the accident.
Furthermore, also a complex mechanism involving estrogen signaling has been demonstrated to play a role in thyrocyte proliferation: hormones have an indirect effect through increased secretion of thyroxine binding globulin and a direct effect through binding to estrogen receptors (ERα and ERβ) present in normal and neoplastic thyroid cells [15, 16]. As for Cyprus and Italy, data show a significant number of cases and females seem to be more affected in the 10–14 and 15–19 age groups, while males appear to be mostly involved when aged 15–19 years old. A sensible difference between the two genders emerges, supporting the plausible role of estrogens in the development of thyroid cancer [17]. This hypothesis is further supported by the much higher incidence of the condition in females aged 15–19 years old compared to females aged 10–14 years old. However, Lebbink et al. [18] found a female predominance in differentiated TC even in prepubertal girls < 10 years old, who had not been exposed to a surge of estrogen levels yet. This finding is controversial, since the vast majority of recent works claimed that increased age results in an increasingly disproportionate number of females affected compared to their male peers, with nearly a 6:1 ratio by 15–19 years of age [19]. The underlying cause is speculated to be due to estrogen exposure during mini-puberty or estrogen derived from adipose tissue, as suggested by Derwahl and Nicula, Paulson et al., and Tawde and Jeyakumar [17, 19, 20].
An interesting aspect to be considered is that differently from adults, thyroid nodules are more rarely palpable in children, leading to delayed diagnosis at a more advanced stage of disease. Moreover, pediatric thyroid nodules carry a 2-to-fivefold higher risk of malignancy [21] and present differences in terms of histological and oncogenic profiles with respect to adult series [22,23,24,25,26]. Also, treatment-related morbidity remains a substantial element [27]. Indeed, it is well known that thyroidectomy can be associated with a considerable rate of complications such as hypoparathyroidism and recurrent laryngeal nerve injury. For all of these reasons, a more conservative approach such as hemithyroidectomy should be preferred when feasible, to reduce the aforementioned risks [28,29,30,31], especially if dealing with early-stage diagnosis and small nodules. Thus, early diagnosis is crucial to be performed and, to do so, a high suspicion level must be maintained given the most recent epidemiological trends.
It must be noted that this study presents some limitations, such as the lacking data of other European countries rather than Belarus prior to 1998. Therefore, a comparison between the peak occurred in that period of time cannot be properly performed, arising some sort of bias in the interpretation of the available data. Moreover, in the database analyzed, no data were available regarding the histopathological characteristics of TC; therefore, deeper studies should be conducted.
Conclusions
Data interpolation demonstrated an increasing trend in the incidence of thyroid cancer in the adolescent population during the last 30 years. This data is particularly relevant in the most recent years in Italy.
Further correlational studies will be required aiming at understanding the underlying causes for this phenomenon, such as increased ultrasound screening or environmental factors. A timely diagnosis of thyroid carcinoma allows a prompt surgical treatment with a more conservative approach, less postoperative complications, and better prognosis. To sum up, the data analysis underlines the necessity to develop specific management strategies for the pediatric population, in order to face the increasing rates of thyroid cancers in the pediatric field and to offer optimal surgical treatment and avoid unnecessary invasive approaches.
References
Massimino M, Evans DB, Podda M, Spinelli C, Collini P, Pizzi N, Bleyer A (2018) Thyroid cancer in adolescents and young adults. Pediatr Blood Cancer 65(8):e27025. https://doi.org/10.1002/pbc.27025
Silverman DA, Wanner R, Waltz P, Old MO, Jatana KR (2021) Pediatric head and neck malignancies. IntechOpen. https://www.intechopen.com/chapters/77962. Accessed 20 Oct 2021
Bernier MO, Withrow DR, Berrington de Gonzalez A, Lam CJK, Linet MS, Kitahara CM, Shiels MS (2019) Trends in pediatric thyroid cancer incidence in the United States, 1998–2013. Cancer 125(14):2497–2505. https://doi.org/10.1002/cncr.32125
Nigro E, Orlandella FM, Polito R, Mariniello RM, Monaco ML, Mallardo M, De Stefano AE, Iervolino PLC, Salvatore G, Daniele A (2021) Adiponectin and leptin exert antagonizing effects on proliferation and motility of papillary thyroid cancer cell lines. J Physiol Biochem 77(2):237–248. https://doi.org/10.1007/s13105-021-00789-x
Zhang Q, Hu M, Wu H, Niu Q, Lu X, He J, Huang F (2021) Plasma polybrominated diphenyl ethers, urinary heavy metals and the risk of thyroid cancer: a case-control study in China. Environ Pollut 15(269):116162. https://doi.org/10.1016/j.envpol.2020.116162
Khatami M (2009) Inflammation, aging, and cancer: tumoricidal versus tumorigenesis of immunity. Cell Biochem Biophys 55:55–79. https://doi.org/10.1007/s12013-009-9059-2
Kitahara CM, Sosa JA (2016) The changing incidence of thyroid cancer. Nat Rev Endocrinol 12(11):646–653. https://doi.org/10.1038/nrendo.2016.110
Vaccarella S, Lortet-Tieulent J, Colombet M, Davies L, Stiller CA, Schüz J, Togawa K, Bray F, Franceschi S, Dal Maso L, Steliarova-Foucher È (2021) Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol 9(3):144–152. https://doi.org/10.1016/S2213-8587(20)30401-0
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (2017) Cancer incidence in five continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer. https://ci5.iarc.fr. Accessed 20 Oct 2021
Sprague BL, Andersen SW, Trentham-Dietz A (2008) Thyroid cancer incidence and socioeconomic indicators of health care access. In: Springer (ed) Cancer Causes Control 19(6):585–593
Williams D (2008) Radiation carcinogenesis: lessons from Chernobyl. Oncogene 27(Suppl 2):S9-18. https://doi.org/10.1038/onc.2009.349
Mitsutake N, Fukushima T, Matsuse M, Rogounovitch T, Saenko V, Uchino S, Ito M, Suzuki K, Suzuki S, Yamashita S (2015) BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl. Sci Rep 5:16976. https://doi.org/10.1038/srep16976
Feldt-Rasmussen U (2001) Iodine and cancer. Thyroid 11(5):483–486. https://doi.org/10.1089/105072501300176435
Cahoon EK, Nadyrov EA, Polyanskaya ON, Yauseyenka VV, Veyalkin IV, Yeudachkova TI, Maskvicheva TI, Minenko VF, Liu W, Drozdovitch V, Mabuchi K, Little MP, Zablotska LB, McConnell RJ, Hatch M, Peters KO, Rozhko AV, Brenner AV (2017) Risk of thyroid nodules in residents of Belarus exposed to Chernobyl fallout as children and adolescents. J Clin Endocrinol Metab 102(7):2207–2217. https://doi.org/10.1210/jc.2016-3842
Coelho RG, Fortunato RS, Carvalho DP (2018) Metabolic Reprogramming in Thyroid Carcinoma. Front Oncol 23(8):82. https://doi.org/10.3389/fonc.2018.00082
Alsen M, Sinclair C, Cooke P, Ziadkhanpour K, Genden E, van Gerwen M (2021) Endocrine disrupting chemicals and thyroid cancer: an overview. Toxics 9(1):14. https://doi.org/10.3390/toxics9010014
Derwahl M, Nicula D (2014) Estrogen and its role in thyroid cancer. Endocr Relat Cancer 21(5):T273–T283. https://doi.org/10.1530/ERC-14-0053
Lebbink CA, van den Broek MFM, Kwast ABG, Derikx JPM, Dierselhuis MP, Kruijff S, Links TP, van Trotsenburg ASP, Valk GD, Vriens MR, Verrijn Stuart AA, van Santen HM, Karim-Kos HE (2021) Opposite incidence trends for differentiated and medullary thyroid cancer in young Dutch patients over a 30-year time span. Cancers (Basel) 13(20):5104. https://doi.org/10.3390/cancers13205104. Erratum in: Cancers (Basel). 2022 Jun 14;14(12): PMID: 34680253; PMCID: PMC8534285
Paulson VA, Rudzinski ER, Hawkins DS (2019) Thyroid cancer in the pediatric population. Genes (Basel) 10(9):723. https://doi.org/10.3390/genes10090723. PMID: 31540418; PMCID: PMC6771006
Tawde A, Jeyakumar A (2022) Surveillance, Epidemiology, and End Results Database update for pediatric thyroid carcinomas incidence and survival trends 2000–2016. Int J Pediatr Otorhinolaryngol 153:111038. https://doi.org/10.1016/j.ijporl.2021.111038. Epub 2022 Jan 4. PMID: 34998202
Niedziela M (2006) Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer 13(2):427–453. https://doi.org/10.1677/erc.1.00882
Spinelli C, Tognetti F, Strambi S, Morganti R, Massimino M, Collini P (2018) Cervical lymph node metastases of papillary thyroid carcinoma, in the central and lateral compartments, in children and adolescents: predictive factors. World J Surg 42(8):2444–2453. https://doi.org/10.1007/s00268-018-4487-z
Spinelli C, Rallo L, Morganti R, Mazzotti V, Inserra A, Cecchetto G, Massimino M, Collini P, Strambi S (2019) Surgical management of follicular thyroid carcinoma in children and adolescents: a study of 30 cases. J Pediatr Surg 54(3):521–526. https://doi.org/10.1016/j.jpedsurg.2018.05.017
Spinelli C, Strambi S, Bakkar S, Nosiglia A, Elia G, Bertocchini A, Calani C, Leoni M, Morganti R, Materazzi G (2020) Surgical management of diffuse sclerosing variant of papillary thyroid carcinoma. Experience in 25 patients. World J Surg 44(1):155–162. https://doi.org/10.1007/s00268-019-05230-5
Spinelli C, Piccolotti I, Bertocchini A, Morganti R, Materazzi G, Tonacchera M, Strambi S (2021) Familial non-medullary thyroid carcinoma in pediatric age: our surgical experience. World J Surg 45(8):2473–2479. https://doi.org/10.1007/s00268-021-06104-5
Spinelli C, Tognetti F, Rallo L, Cappelli G, Gucci M, Strambi S (2017) Pediatric versus adult papillary thyroid carcinoma: different diseases requiring different surgical approaches. J Head Neck Spine Surg 1(1):555554. https://doi.org/10.19080/JHNSS.2017.01.555554
Selvakumar T, Nies M, Klein Hesselink MS, Brouwers AH, van der Horst-Schrivers ANA, Klein Hesselink EN, Tissing WJE, Vissink A, Links TP, Bocca G, Burgerhof JGM, van Dam EWCM, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Smit JWA, Plukker JTM, Ronckers CM, van Santen HM (2018) Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma. J Nucl Med. https://doi.org/10.2967/jnumed.118.212449
Keane A, Bann DV, Wilson MN, Goldenberg D (2021) Pediatric thyroid cancer: to whom do you send the referral? Cancers (Basel) 13(17):4416. https://doi.org/10.3390/cancers13174416
Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S (2015) American Thyroid Association Guidelines Task Force. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25(7):716–759. https://doi.org/10.1089/thy.2014.0460
Spinelli C, Rossi L, Piscioneri J, Strambi S, Antonelli A, Ferrari A, Massimino M, Miccoli P (2016) Pediatric differentiated thyroid cancer: when to perform conservative and radical surgery. Curr Pediatr Rev 12(4):247–252. https://doi.org/10.2174/1573396312666161014092023
Spinelli C, Strambi S, Rossi L, Bakkar S, Massimino M, Ferrari A, Collini P, Cecchetto G, Bisogno G, Inserra A, Bianco F, Miccoli P (2016) Surgical management of papillary thyroid carcinoma in childhood and adolescence: an Italian multicenter study on 250 patients. J Endocrinol Invest 39(9):1055–1059. https://doi.org/10.1007/s40618-016-0474-0
Funding
Open access funding provided by Università di Pisa within the CRUI-CARE Agreement.
Author information
Authors and Affiliations
Contributions
C.S., M.G, P.M., L.N., A.A.: conception and design, drafting the article, acquisition of data. R.M.: acquisition of data, analysis, and interpretation of data. C.O., M.G., B.S.: writing of the manuscript. A.M.: critical review. All of the co-authors interpreted the data and participated in the completion of the article. All of the co-authors approved the final version of the article.
Corresponding author
Ethics declarations
Ethics approval
N/A
Consent to participate
N/A
Consent for publication
N/A
Competing interests
The authors declare no competing interests.
Additional information
Communicated by Peter de Winter
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Spinelli, C., Ghionzoli, M., Oreglio, C. et al. Increased trend of thyroid cancer in childhood over the last 30 years in EU countries: a call for the pediatric surgeon. Eur J Pediatr 181, 3907–3913 (2022). https://doi.org/10.1007/s00431-022-04596-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-022-04596-4